Boehringer Ingelheim(China) Investment Co.,Ltd.：

Please note that on November 3, 2025, CFDI sent the Notification of Drug Remote Inspection Results of Alteplase for Injection to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon.

Contact: Dong Fang

Tel.+86 10 68441633

Center for Food and Drug Inspection of NMPA
November 3, 2025